ConMed Corporation, in a press statement, announced that its financial results from the second quarter 2023 showed increased revenue and sales.
ConMed reported sales of $317.7 millions, an increase of 14.6% over the previous year. The company also reported a 17.1% growth in domestic revenues and an 11.7% increase for international revenues.
“Our team drove excellent growth across both orthopedics and general surgery during the second quarter, building on the momentum we generated during the first 3 months of the year,” Curt R. Hartman, president, CEO and chair of the board of ConMed Corporation,
